Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. (2020)

First Author: Lacy SE
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2019003535

PubMed Identifier: 32187361

Publication URI: http://europepmc.org/abstract/MED/32187361

Type: Journal Article/Review

Volume: 135

Parent Publication: Blood

Issue: 20

ISSN: 0006-4971